Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference134 articles.
1. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035;Arnold;Gut,2020
2. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease;Buas;Semin Radiat Oncol,2013
3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;The Lancet,2010
4. Predictive role of microsatellite instability for of PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials;Pietrantonio;ESMO Open,2021
5. Panda A, Mehnert JM, Hirshfield KM, Riedlinger G, Damare S, Saunders T, et al. Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer. J Natl Cancer Inst 2018;110:316–20. DOI: 10.1093/jnci/djx213.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Good response to cadonilimab as first-line treatment in superaged patient with advanced gastric cancer: a case report;Immunotherapy;2024-09-11
2. Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial;Digestive and Liver Disease;2024-08
3. Good Response to Cadonilimab (Pd-1/Ctla-4 Bi-Specific Antibody) Combined with Chemotherapy as First-Line Treatment In Superaged Patient with Her2-Negative Advanced Gastric Cancer: A Case Report;2024
4. State of the scientific evidence and recommendations for the management of older patients with gastric cancer;Journal of Geriatric Oncology;2023-11
5. Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients;International Journal of Clinical Oncology;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3